These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. Bartlett W; Skinner JA; Gooding CR; Carrington RW; Flanagan AM; Briggs TW; Bentley G J Bone Joint Surg Br; 2005 May; 87(5):640-5. PubMed ID: 15855365 [TBL] [Abstract][Full Text] [Related]
30. Patellofemoral full-thickness chondral defects treated with second-generation autologous chondrocyte implantation: results at 5 years' follow-up. Gobbi A; Kon E; Berruto M; Filardo G; Delcogliano M; Boldrini L; Bathan L; Marcacci M Am J Sports Med; 2009 Jun; 37(6):1083-92. PubMed ID: 19465733 [TBL] [Abstract][Full Text] [Related]
31. Autologous chondrocyte implantation and anteromedialization for isolated patellar articular cartilage lesions: 5- to 11-year follow-up. Gillogly SD; Arnold RM Am J Sports Med; 2014 Apr; 42(4):912-20. PubMed ID: 24519181 [TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Nejadnik H; Hui JH; Feng Choong EP; Tai BC; Lee EH Am J Sports Med; 2010 Jun; 38(6):1110-6. PubMed ID: 20392971 [TBL] [Abstract][Full Text] [Related]
33. [Clinical results after three years use of matrix-associated ACT for the treatment of osteochondral defects of the knee]. Maus U; Schneider U; Gravius S; Müller-Rath R; Mumme T; Miltner O; Bauer D; Niedhart C; Andereya S Z Orthop Unfall; 2008; 146(1):31-7. PubMed ID: 18324579 [TBL] [Abstract][Full Text] [Related]
34. Articular cartilage defects of the distal femur in children and adolescents: treatment with autologous chondrocyte implantation. Micheli LJ; Moseley JB; Anderson AF; Browne JE; Erggelet C; Arciero R; Fu FH; Mandelbaum BR J Pediatr Orthop; 2006; 26(4):455-60. PubMed ID: 16791061 [TBL] [Abstract][Full Text] [Related]
35. Long-term results of autologous chondrocyte implantation in the knee for chronic chondral and osteochondral defects. Biant LC; Bentley G; Vijayan S; Skinner JA; Carrington RW Am J Sports Med; 2014 Sep; 42(9):2178-83. PubMed ID: 25002462 [TBL] [Abstract][Full Text] [Related]
36. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years. Crawford DC; DeBerardino TM; Williams RJ J Bone Joint Surg Am; 2012 Jun; 94(11):979-89. PubMed ID: 22637204 [TBL] [Abstract][Full Text] [Related]
37. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Saris DB; Vanlauwe J; Victor J; Almqvist KF; Verdonk R; Bellemans J; Luyten FP; Am J Sports Med; 2009 Nov; 37 Suppl 1():10S-19S. PubMed ID: 19846694 [TBL] [Abstract][Full Text] [Related]
38. Long-term Outcomes of Autologous Chondrocyte Implantation in Adolescent Patients. Ogura T; Bryant T; Minas T Am J Sports Med; 2017 Apr; 45(5):1066-1074. PubMed ID: 28129512 [TBL] [Abstract][Full Text] [Related]
39. Treatment of full-thickness chondral defects with hyalograft C in the knee: a prospective clinical case series with 2 to 7 years' follow-up. Nehrer S; Dorotka R; Domayer S; Stelzeneder D; Kotz R Am J Sports Med; 2009 Nov; 37 Suppl 1():81S-87S. PubMed ID: 19861701 [TBL] [Abstract][Full Text] [Related]
40. A randomized trial comparing accelerated and traditional approaches to postoperative weightbearing rehabilitation after matrix-induced autologous chondrocyte implantation: findings at 5 years. Ebert JR; Fallon M; Zheng MH; Wood DJ; Ackland TR Am J Sports Med; 2012 Jul; 40(7):1527-37. PubMed ID: 22539536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]